# Efficacy of Intrathecal Clonidine Versus Neostigmine as Adjuvants to Bupivacaine on Postoperative Maternal and Fetal Outcomes After Elective Cesarean Section

> **NCT05943613** · PHASE1 · UNKNOWN · sponsor: **Assiut University** · enrollment: 111 (estimated)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** Clonidine

## Key facts

- **NCT ID:** NCT05943613
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 111 (ESTIMATED)
- **Last updated:** 2023-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05943613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05943613, "Efficacy of Intrathecal Clonidine Versus Neostigmine as Adjuvants to Bupivacaine on Postoperative Maternal and Fetal Outcomes After Elective Cesarean Section". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05943613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*